Insider Shareholders with Direct Ownership of Adagio Therapeutics, Inc. (ADGI)
This section provides a comprehensive overview of the insiders with direct ownership of Adagio Therapeutics, Inc. (ADGI). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Adagio Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
| 25,860,700 | 6,158,089 | 21,687,906 $71.8 Million | 3 |
Jan 19, 2024
Reduced 18.74%
|
|
|
Mithril Ii Lp
> 10% Shareholder |
11,241,580 | 0 | 11,241,580 $37.2 Million | 1 |
Aug 10, 2021
Added 15.08%
|
|
Jill Andersen
Chief Legal Officer, Secretary |
165,000 | 82,754 | 84,446 $279,516 | 3 |
Aug 19, 2025
Reduced 36.91%
|
|
Timothy Edward Lee
Chief Commercial Officer |
99,000 | 49,656 | 59,344 $196,428 | 3 |
Aug 19, 2025
Reduced 33.31%
|
|
Robert D. Allen Iii
Chief Scientific Officer |
99,000 | 45,932 | 53,068 $175,655 | 3 |
Aug 19, 2025
Reduced 34.07%
|
|
William E. Duke
Chief Financial Officer |
99,000 | 49,656 | 49,344 $163,328 | 3 |
Aug 19, 2025
Reduced 37.53%
|
|
Julie Green
Chief Human Resources Officer |
99,000 | 49,656 | 49,344 $163,328 | 3 |
Aug 19, 2025
Reduced 37.53%
|
|
David Hering
Chief Executive Officer |
8,000 | 0 | 8,000 $26,480 | 1 |
Sep 01, 2022
Added 50.0%
|